From Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner:

Acetylon Pharmaceuticals logo
Acetylon Pharmaceuticals logo

Acetylon is developing targeted HDAC inhibitor drugs.